COFCO Biotechnology Co., Ltd.
000930.SZ · SHZ
12/31/2024 | 12/31/2023 | 12/31/2022 | 12/31/2021 | |
|---|---|---|---|---|
| Market Cap | CN¥10,331,025 | CN¥12,356,707 | CN¥15,593,687 | CN¥20,280,355 |
| - Cash | CN¥1,909,371 | CN¥1,481,142 | CN¥1,016,637 | CN¥1,115,957 |
| + Debt | CN¥4,341,965 | CN¥3,761,144 | CN¥3,226,039 | CN¥3,395,423 |
| Enterprise Value | CN¥12,763,619 | CN¥14,636,709 | CN¥17,803,089 | CN¥22,559,820 |
| Revenue | CN¥20,053,355 | CN¥20,378,950 | CN¥19,918,051 | CN¥23,559,594 |
| % Growth | -1.6% | 2.3% | -15.5% | – |
| Gross Profit | CN¥1,145,721 | CN¥581,399 | CN¥2,080,626 | CN¥2,437,133 |
| % Margin | 5.7% | 2.9% | 10.4% | 10.3% |
| EBITDA | CN¥603,970 | CN¥47,105 | CN¥1,966,842 | CN¥2,119,254 |
| % Margin | 3% | 0.2% | 9.9% | 9% |
| Net Income | CN¥25,130 | -CN¥601,630 | CN¥1,058,529 | CN¥1,129,603 |
| % Margin | 0.1% | -3% | 5.3% | 4.8% |
| EPS Diluted | 0.014 | -0.327 | 0.57 | 0.605 |
| % Growth | 104.1% | -157.3% | -5.8% | – |
| Operating Cash Flow | CN¥155,812 | CN¥1,957,979 | CN¥708,443 | CN¥4,841,591 |
| Capital Expenditures | -CN¥483,305 | -CN¥634,516 | -CN¥565,780 | -CN¥1,109,774 |
| Free Cash Flow | -CN¥327,492 | CN¥1,323,463 | CN¥142,663 | CN¥3,731,817 |